<DOC>
	<DOC>NCT01162967</DOC>
	<brief_summary>The investigators propose the evaluation of posaconazole and benznidazole in humans for the treatment of Chagas disease chronical infection. Exploratory trial of posaconazole antiparasitic activity against Trypanosoma cruzi.</brief_summary>
	<brief_title>Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole</brief_title>
	<detailed_description />
	<mesh_term>Chagas Disease</mesh_term>
	<mesh_term>Benzonidazole</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>Consenting patients with serological evidence of Chagas infection and positive PCR real time</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>